“…While racemic tranylcypromine is known to counteract behavioral effects of reserpine (Tedeschi, Tedeschi, Ames, Cook, Mattis, and Fellows, 1959), the present findings show reserpine-reversal to depend on pharmacological actions present in the (+)-isomer but absent in the (--)-isomer. Tranylcypromine stereoisomers have stereoselective effects on monoamine oxidase inhibition, monoamine uptake mechanisms and catecholamine release (Zirkle, Kaiser, Tedeschi, and Tedeschi, 1962;Horn and Snyder, 1972;Tuomisto, 1978;Reigle, Orsulak, Avni, Platz, and Schildkraut, 1980;Reynolds, Riederer, and Rausch, 1980), but it is unknown whether these actions can account fully for their stereoselective effects in reserpinized rats. Perhaps further studies on stereoselective pharmacological effects of tranylcypromine stereoisomers can clarify the molecular basis of reserpine-induced depression and of its reversal by psychoactive drugs.…”